Lista de obras - Olivier Cheneval - Dominio Público Uruguay

Accurate de novo design of hyperstable constrained peptides

artículo científico publicado en 2016

Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

artículo científico publicado en 2017

Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption

artículo científico publicado en 2018

Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro

artículo científico publicado en 2014

Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.

artículo científico publicado en 2013

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

artículo científico publicado en 2018

Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions

artículo científico publicado en 2016

Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide

artículo científico publicado en 2016

Fmoc-based synthesis of disulfide-rich cyclic peptides.

artículo científico publicado en 2014

Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.

artículo científico publicado en 2016

Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen

artículo científico publicado en 2006

Molecular characterisation of endogenous snake venom metalloproteinase inhibitors

artículo científico publicado en 2007

Optimization of the cyclotide framework to improve cell penetration properties

artículo científico publicado en 2015

Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.

artículo científico publicado en 2017

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1

artículo científico publicado en 2018

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability

artículo científico publicado en 2014

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties

artículo científico publicado en 2017

Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.

artículo científico publicado en 2017

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

artículo científico publicado en 2014

Targeted Delivery of Cyclotides via Conjugation to a Nanobody

artículo científico publicado en 2018

The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cells.

artículo científico publicado en 2014

The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues

artículo científico publicado en 2007

Using the MCoTI-II Cyclotide Scaffold To Design a Stable Cyclic Peptide Antagonist of SET, a Protein Overexpressed in Human Cancer

artículo científico publicado en 2015

Lista de obras de Olivier Cheneval

Accurate de novo design of hyperstable constrained peptides

Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption

Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro

Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions

Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide

Fmoc-based synthesis of disulfide-rich cyclic peptides.

Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.

Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen

Molecular characterisation of endogenous snake venom metalloproteinase inhibitors

Optimization of the cyclotide framework to improve cell penetration properties

Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties

Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Targeted Delivery of Cyclotides via Conjugation to a Nanobody

The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cells.

The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues

Using the MCoTI-II Cyclotide Scaffold To Design a Stable Cyclic Peptide Antagonist of SET, a Protein Overexpressed in Human Cancer